[
  {
    "ts": "2026-02-23T11:00:00+00:00",
    "headline": "IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer",
    "summary": "IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D a",
    "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-appointment-dr-110000638.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "2a2a216a-88c8-33f7-bf2a-0ed4f9bbd841",
      "content": {
        "id": "2a2a216a-88c8-33f7-bf2a-0ed4f9bbd841",
        "contentType": "STORY",
        "title": "IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer",
        "description": "",
        "summary": "IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D a",
        "pubDate": "2026-02-23T11:00:00Z",
        "displayTime": "2026-02-23T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b53b2c167935532309987db78b249c89",
          "originalWidth": 400,
          "originalHeight": 261,
          "caption": "(PRNewsfoto/IDEAYA Biosciences, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/smKChLwQ.SonclD79zSdzg--~B/aD0yNjE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b53b2c167935532309987db78b249c89.cf.webp",
              "width": 400,
              "height": 261,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R0fazI2CBgEFiEDtnaOWYg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b53b2c167935532309987db78b249c89.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-appointment-dr-110000638.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-appointment-dr-110000638.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDYA"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T13:13:00+00:00",
    "headline": "Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs",
    "summary": "JNJ's diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with ABBV for healthcare dominance.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-vs-abbvie-growth-131300265.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e7550c84-00ed-39f9-8dff-94d44d403848",
      "content": {
        "id": "e7550c84-00ed-39f9-8dff-94d44d403848",
        "contentType": "STORY",
        "title": "Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs",
        "description": "",
        "summary": "JNJ's diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with ABBV for healthcare dominance.",
        "pubDate": "2026-02-23T13:13:00Z",
        "displayTime": "2026-02-23T13:13:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rR6iZHXu8FRY2qc4ebuBNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TXlDKOevAW4cJAnlMECSwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-vs-abbvie-growth-131300265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-vs-abbvie-growth-131300265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T13:02:45+00:00",
    "headline": "Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather",
    "summary": "It’s been a fantastic 2026 for most dividend stocks so far this year, but most dividend-payers took a break last week. The Schwab U.S. Dividend Equity ETF was flat while the Consumer Staples SPDR fell 1.8%. With the stock market opening in about 90 minutes for the week, let’s take a look back at which ... Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather",
    "url": "https://247wallst.com/investing/2026/02/23/crown-castle-and-att-tumble-while-coca-cola-rises-as-dividened-stocks-take-a-breather/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bf494f48-c6f9-326b-97fd-c5b7f24b94db",
      "content": {
        "id": "bf494f48-c6f9-326b-97fd-c5b7f24b94db",
        "contentType": "STORY",
        "title": "Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather",
        "description": "",
        "summary": "It’s been a fantastic 2026 for most dividend stocks so far this year, but most dividend-payers took a break last week. The Schwab U.S. Dividend Equity ETF was flat while the Consumer Staples SPDR fell 1.8%. With the stock market opening in about 90 minutes for the week, let’s take a look back at which ... Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather",
        "pubDate": "2026-02-23T13:02:45Z",
        "displayTime": "2026-02-23T13:02:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/419479fd733907649f73d500314b88a8",
          "originalWidth": 1376,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LWOXIcpwF0b2agA4vYBIqw--~B/aD03Njg7dz0xMzc2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/419479fd733907649f73d500314b88a8.cf.webp",
              "width": 1376,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/36JIWOVw7DmIJCEiukkc7w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/419479fd733907649f73d500314b88a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/23/crown-castle-and-att-tumble-while-coca-cola-rises-as-dividened-stocks-take-a-breather/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crown-castle-t-tumble-while-130245197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CCI"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "T"
            },
            {
              "symbol": "T-PA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]